Second Sight Reports Second Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/26/2026
- Nasdaq lags on angst over AI spending ahead of earnings reports
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil falls on report China pushing for end US-Iran war
- Why Meta, Microsoft, and Nvidia are championing open-weight AI
- FDA approves Tylenol with Naproxen as first OTC combo pain reliever
- AMD (AMD) PT Raised to $1,250 at Baird
- Pakistan, Iran explore path towards new talks with US in a China-initiated push, sources say
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Nasdaq lags on angst over AI spending ahead of earnings reports
Second Sight Medical (EYES) Reports Q2 Loss of $0.17/Share
July 28, 2016 4:09 PM EDTSecond Sight Medical (NASDAQ: EYES) reported Q2 EPS of ($0.17), versus ($0.12) reported last year. Revenue for the quarter came in at $1.04 million, versus $2.66 million reported last year.
For earnings history and earnings-related data on Second Sight Medical (EYES) click here.
... More